8-K
filed December 8, 2023, 6:59 PM ET
ticker XBIO
CIK 0001534525
other material
confidence high
sentiment negative
materiality 0.15
Xenetic Biosciences shareholders reject non-binding say-on-pay proposal at 2023 annual meeting
Xenetic Biosciences, Inc.
- Nine director nominees elected; Dr. Dmitry Genkin received highest 'for' votes (461,413), Jeffrey Eisenberg lowest (255,632).
- Ratification of Marcum LLP as auditor approved with 804,522 for, 21,792 against.
- Say-on-pay advisory proposal failed: 153,605 for, 318,665 against, 2,112 abstained; received less than one-third of votes cast.
- Broker non-votes of 356,015 on director elections and say-on-pay due to routine/non-routine mix.
Key facts
Extracted from this filing and checked against the source text.
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.99
Xenetic Biosciences, Inc. shareholders approved Election of nine nominees to the Board of Directors at the 2023-12-06 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2023-12-06
Exact text from the filing
The Company’s stockholders approved the election of the following nine nominees with each director receiving votes as follows:
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.99
Xenetic Biosciences, Inc. shareholders rejected Advisory vote on named executive officer compensation at the 2023-12-06 meeting.
- Proposal
- say on pay
- Outcome
- failed
- Meeting
- 2023-12-06
Exact text from the filing
The Company’s stockholders voted upon, on a non-binding, advisory basis, the Company’s named executive officer compensation. The proposal did not receive an affirmative vote of a majority of the shares cast.
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.99
Xenetic Biosciences, Inc. shareholders approved Ratification of selection of Marcum LLP as independent registered public accounting firm for fiscal year ending December 31, 2023 at the 2023-12-06 meeting.
- Proposal
- auditor ratification
- Outcome
- passed
- Meeting
- 2023-12-06
Exact text from the filing
The Company’s stockholders voted upon and approved the ratification of the selection of Marcum LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2023.
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.